Every biopharma transformation has a moment that looks like progress. A strategy is approved, the town hall occurs, and the announcement goes out. Six months later, little has changed on the ground. Teams are still working the old way. Leaders are hedging. The initiative is technically alive but effectively stuck.

Research consistently puts the failure rate of large-scale change initiatives at 70%. What is even more telling is how rarely that failure traces back to strategy. Most strategies are directionally sound and, in many instances, supported by a set of well-defined tactics. The problem is that the organization was ill-prepared to execute them.

The announcement is not the execution

Senior leaders spend months refining a transformation plan and hours preparing the announcement, then hand it off as if communication and execution are the same thing. Unfortunately, they aren’t. What follows such an organizational announcement requires just as much deliberate design as the strategy that preceded it. These include:

  • Translating the initiative strategy into required changes in day-to-day work across functions
  • Building team-level transition plans with clear accountabilities, points of interconnectedness, and proper sequencing
  • Coaching individuals through the personal dynamics of change โ€” the “me issues” that determine whether people commit or resist

Without this, the pattern is predictable. A restructuring is announced. Field leaders repeat the messaging without truly processing and owning it. Middle managers pass it along without connecting it to their teams’ reality. Employees hear the words but can’t determine what to do differently on Monday. What shows up as resistance is simply unresolved ambiguity.

Where transformations actually break down

The failure point can rarely be traced back to misalignment at the top. It is the leadership layers underneath where things become untracked. Most organizations underestimate the degree to which change execution depends on leader-level sensemaking at all levels:

  • Can a director translate strategy into operational trade-offs for their team?
  • Can a first-line leader adeptly handle push-back without escalating uncertainty?
  • Can middle management connect enterprise priorities to local realities without diluting them?

When this capability is lacking and change readiness has not been properly assessed, the organization defaults to preservation mode. Many employees donโ€™t commit and continue doing what they know how to do.

What it takes

A vision is necessary, but not sufficient. The gap between a compelling vision and an organization that knows how to execute it is where most change initiatives lose momentum and produce uneven results. It’s a gap that can be bridged but requires specific, structured work at every level of the leadership hierarchy.

Leaders across all levels need three things that don’t come from a town hall:

  • Localized business case: The business case for change in their own words, not the company’s talking points
  • Risk visibility: A clear view of the risks specific to their team, not a generic risk register from headquarters
  • Change leadership capability: The temperament, skill, and steadiness to support their direct reports through the transition while managing their own reaction to change

The last point is consistently underestimated.

Leaders who have not experienced or been helped through their own transition find it challenging to guide others through theirs. These individuals tend to project uncertainty downward, hedge on the change messaging, and inadvertently signal that employee commitment is optional. Unfortunately, this pattern is quite common and contributes to the less than stellar success rate historically cited for large change initiatives.

The practical question for commercial leaders

Organizations canโ€™t successfully execute a change initiative through announcements alone. Real, measurable change, especially at the enterprise level requires repeated, structured action at every level of the organizationโ€™s leadership hierarchy.  This can happen only when leaders have been properly prepared to lead the change.

For CCOs and CMOs navigating change initiatives such as launches, restructurings, or market access shifts, the question is usually not whether the strategy is correct. but rather whether their leadership system can navigate the change and execute on the strategy and tactics. Could your leaders, from senior director down to first-line manager, walk into a team meeting tomorrow and translate the change initiative strategy into clear, actionable direction? Could they manage resistance in a way that builds commitment?

This is where the real transformation work takes place.


Is your organization ready to execute your next change initiative โ€” or just ready to announce it? WLHโ€˜s Change Readiness Diagnostic identifies where your leadership cascade is likely to break down before it does. Our consultants can work with you to ensure your leaders are prepared to effectively navigate changeโ€ฆ Schedule a conversation at wlhconsulting.com.

Author
Wendy L. Heckelman, Ph.D.

Dr. Wendy Heckelman, president and founder of WLH Consulting, Inc. has over 30 years of experience working with Fortune 100 industry clients. These include pharmaceutical, biotech, health care, animal health medicines, and consumer products, as well as international non-profit organizations and growing entrepreneurial companies.

Tags
Change LeadershipChange Leadership ExpertBiopharma TransformationChange ReadinessTransformation Execution